| LC control no. | no2010135192 |
|---|---|
| Descriptive conventions | rda |
| Corporate name heading | AstraZeneca (Firm) |
| Variant(s) | Astra Zeneca (Firm) AstraZeneca Pharmaceuticals |
| See also | Component of merger: Zeneca Group PLC Component of mergerr: Astra (Firm : Sweden) |
| Beginning date | 1999-04-06 |
| Located | Cambridge (England) |
| Field of activity | Drugs--Design Biopharmaceutics--Design |
| Found in | Its Web site, Aug. 16, 2010 (AstraZeneca; formed on Apr. 6, 1999 through the merger of Astra AB of Sweden and Zeneca Group PLC of the UK) Recognizing extrapyramidal symptoms, 2001: VHS tape spine (AstraZeneca Pharmaceuticals LP) Wikipedia, searched May 28, 2020 (AstraZeneca; multinational pharmaceutical and biopharmaceutical company; headquarters: Cambridge, England) <https://en.wikipedia.org/wiki/AstraZeneca> |
 |  |  |
View this record in: MARCXML | LC Authorities & Vocabularies | VIAF (Virtual International Authority File)
